Skip to main
ABT

Abbott Labs (ABT) Stock Forecast & Price Target

Abbott Labs (ABT) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 45%
Buy 55%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Abbott Laboratories is well-positioned in the medical device market, with a strong pipeline of new products and a focus on high-growth areas. The company's strategic investments and commitment to sustainability make it an attractive long-term investment. While risks such as competition and policy changes exist, ABT's diversified business model and focus on chronic conditions make it less susceptible to fluctuations in healthcare demand. With a solid performance in Q2 and a raised sales and earnings forecast, ABT is expected to continue its growth trajectory.

Bears say

Abbott Laboratories is rated as a Buy with a $134 price target and a 21x 12-24 month adjusted EPS forecast. With a diversified portfolio and strong presence in high-growth markets such as Medical Devices and Diagnostics, the company has a competitive advantage. Additionally, ABT has made efforts to integrate sustainability into its strategy and has strong financials with projected sales growth of 6.5%-7.5% and adjusted EPS of $5.45-$5.60.

Abbott Labs (ABT) has been analyzed by 20 analysts, with a consensus rating of Buy. 45% of analysts recommend a Strong Buy, 55% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Abbott Labs (ABT) Forecast

Analysts have given Abbott Labs (ABT) a Buy based on their latest research and market trends.

According to 20 analysts, Abbott Labs (ABT) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $123.35, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $123.35, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Abbott Labs (ABT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.